Overview

A Multinational, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Investigate the Efficacy, Safety and Duration of Effect of a Single Administration of Various Doses of Cetrorelix SR in Subjects With Histologically Confirmed End

Status:
Completed

Trial end date:
2006-09-01

Target enrollment:

Participant gender:

Summary

Identify effective doses of cetrorelix SR in the treatment of symptoms of endometriosis, describe dose effect relationship and duration of symptom relief

Phase:

Phase 2

Details

Lead Sponsor:

Solvay Pharmaceuticals

Treatments:

Cetrorelix